Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fabien V.K. Diomandé"'
Autor:
Jessica R. MacNeil, Isaïe Medah, Daouda Koussoubé, Ryan T. Novak, Amanda C. Cohn, Fabien V.K. Diomandé, Denis Yelbeogo, Jean Ludovic Kambou, Tiga F. Tarbangdo, Rasmata Ouédraogo-Traoré, Lassana Sangaré, Cynthia Hatcher, Jeni Vuong, Leonard W. Mayer, Mamoudou H. Djingarey, Thomas A. Clark, Nancy E. Messonnier
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 3, Pp 402-407 (2014)
In 2010, Burkina Faso became the first country to introduce meningococcal serogroup A conjugate vaccine (PsA-TT). During 2012, Burkina Faso reported increases in Neisseria meningitidis serogroup W, raising questions about whether these cases were a n
Externí odkaz:
https://doaj.org/article/721d162d924544658a40e15eafaddf31
Autor:
Charles Sawadogo, Fabien V.K. Diomandé, Claude-Roger Ouandaogo, Patrick L.F. Zuber, Rasmata Ouédraogo-Traoré, Nehemie Mbakuliyemo, Lorenzo Pezzoli, Téné M. Yaméogo, Mamoudou Harouna Djingarey, Bassirou Ouedraogo
Publikováno v:
Vaccine. 30:B46-B51
MenAfriVac™ is a new meningococcal A conjugate vaccine developed to prevent meningitis outbreaks in Africa. It was first introduced during the last quarter of 2010 in three West African countries. We report on the monitoring of adverse events follo
Autor:
MacNeil, Jessica R.1 aji8@cdc.gov, Medah, Isaïe2, Koussoubé, Daouda2, Novak, Ryan T.1, Cohn, Amanda C.1, Diomandé, Fabien V.K.1,3, Yelbeogo, Denis2, Kambou, Jean Ludovic2, Tarbangdo, Tiga F.2, Ouédraogo-Traoré, Rasmata4, Sangaré, Lassana5, Hatcher, Cynthia1, Vuong, Jeni1, Mayer, Leonard W.1, Djingarey, Mamoudou H.3, Clark, Thomas A.1, Messonnier, Nancy E.1
Publikováno v:
Emerging Infectious Diseases. Mar2014, Vol. 20 Issue 3, p394-399. 6p. 2 Charts, 2 Graphs.